But we're not short of funds after the CR which has just happened. Teva fully funding the CHF trials under an agreement which won Biotech Licensing Deal of the Year. Usually milestone payments are triggered by critical delivery points and when this occurs depends on how the testing is going. There is a halfway mark for both Stage 3 clinical trials where the FDA will conduct a review for possible fast tracked approval based on overwhelming efficacy. I have to stop reading the trading posts... it's going to send me spare. Read the AGM presos for starters. Please.
High chance fund raising, page-20
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
-0.010(1.08%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 94.0¢ | 91.5¢ | $1.609M | 1.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 131951 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 22000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |